BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10860189)

  • 1. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
    Gerstein HC; Mann JF; Pogue J; Dinneen SF; Hallé JP; Hoogwerf B; Joyce C; Rashkow A; Young J; Zinman B; Yusuf S
    Diabetes Care; 2000 Apr; 23 Suppl 2():B35-9. PubMed ID: 10860189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
    McQueen MJ; Gerstein HC; Pogue J; Mann JF; Yusuf S
    Am J Kidney Dis; 2006 Dec; 48(6):889-96. PubMed ID: 17162143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors.
    Burgert TS; Dziura J; Yeckel C; Taksali SE; Weiss R; Tamborlane W; Caprio S
    Int J Obes (Lond); 2006 Feb; 30(2):273-80. PubMed ID: 16231019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience.
    Hitha B; Pappachan JM; Pillai HB; Sujathan P; Ramakrishna CD; Jayaprakash K; Raihanathul Misiriya KJ
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):411-9. PubMed ID: 18445902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey.
    Jones CA; Francis ME; Eberhardt MS; Chavers B; Coresh J; Engelgau M; Kusek JW; Byrd-Holt D; Narayan KM; Herman WH; Jones CP; Salive M; Agodoa LY
    Am J Kidney Dis; 2002 Mar; 39(3):445-59. PubMed ID: 11877563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
    Cotter J; Oliveira P; Cunha P; Polónia J
    Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microalbuminuria in diabetic and hypertensive patients and the general population--consequences of various diagnostic criteria--the Nord-Trøndelag Health Study (HUNT).
    Hallan H; Romundstad S; Kvenild K; Holmen J
    Scand J Urol Nephrol; 2003; 37(2):151-8. PubMed ID: 12745725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey.
    Wrone EM; Carnethon MR; Palaniappan L; Fortmann SP;
    Am J Kidney Dis; 2003 Mar; 41(3):580-7. PubMed ID: 12612981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes.
    Donnelly R; Yeung JM; Manning G
    J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95.
    Liese AD; Hense HW; Döring A; Stieber J; Keil U
    J Hum Hypertens; 2001 Nov; 15(11):799-804. PubMed ID: 11687925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria: prevalence in hypertensives and diabetics.
    Cöl M; Ocaktan E; Ozdemir O; Yalçin A; Tunçbilek A
    Acta Med Austriaca; 2004 Feb; 31(1):23-9. PubMed ID: 15259594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes.
    Ko GT; Chan JC; Chow CC; Yeung VT; Chan WB; So WY; Ma RC; Ozaki R; Cockram CS
    Acta Diabetol; 2003 Jun; 40(2):80-4. PubMed ID: 12861405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.
    Lee ET; Howard BV; Wang W; Welty TK; Galloway JM; Best LG; Fabsitz RR; Zhang Y; Yeh J; Devereux RB
    Circulation; 2006 Jun; 113(25):2897-905. PubMed ID: 16769914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microalbuminuria as an early marker for cardiovascular disease.
    de Zeeuw D; Parving HH; Henning RH
    J Am Soc Nephrol; 2006 Aug; 17(8):2100-5. PubMed ID: 16825327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.
    Olsen MH; Wachtell K; Bella JN; Palmieri V; Gerdts E; Smith G; Nieminen MS; Dahlöf B; Ibsen H; Devereux RB
    Am J Hypertens; 2005 Nov; 18(11):1430-6. PubMed ID: 16280277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.